FONR
Price
$12.73
Change
+$0.18 (+1.43%)
Updated
May 9, 12:17 PM (EDT)
Capitalization
131.33M
SAUHY
Price
$13.31
Change
+$0.94 (+7.60%)
Updated
May 8 closing price
Capitalization
26.41B
96 days until earnings call
Ad is loading...

FONR vs SAUHY

Header iconFONR vs SAUHY Comparison
Open Charts FONR vs SAUHYBanner chart's image
Fonar
Price$12.73
Change+$0.18 (+1.43%)
Volume$477
Capitalization131.33M
Straumann Holding AG
Price$13.31
Change+$0.94 (+7.60%)
Volume$172.31K
Capitalization26.41B
FONR vs SAUHY Comparison Chart
Loading...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAUHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FONR vs. SAUHY commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FONR is a StrongBuy and SAUHY is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (FONR: $12.55 vs. SAUHY: $13.31)
Brand notoriety: FONR and SAUHY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FONR: 87% vs. SAUHY: 140%
Market capitalization -- FONR: $131.33M vs. SAUHY: $26.41B
FONR [@Medical Specialties] is valued at $131.33M. SAUHY’s [@Medical Specialties] market capitalization is $26.41B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FONR’s FA Score shows that 0 FA rating(s) are green whileSAUHY’s FA Score has 1 green FA rating(s).

  • FONR’s FA Score: 0 green, 5 red.
  • SAUHY’s FA Score: 1 green, 4 red.
According to our system of comparison, SAUHY is a better buy in the long-term than FONR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FONR’s TA Score shows that 4 TA indicator(s) are bullish while SAUHY’s TA Score has 6 bullish TA indicator(s).

  • FONR’s TA Score: 4 bullish, 4 bearish.
  • SAUHY’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, SAUHY is a better buy in the short-term than FONR.

Price Growth

FONR (@Medical Specialties) experienced а +2.03% price change this week, while SAUHY (@Medical Specialties) price change was +9.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.64%. For the same industry, the average monthly price growth was +8.19%, and the average quarterly price growth was -3.52%.

Reported Earning Dates

FONR is expected to report earnings on Feb 18, 2025.

SAUHY is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Medical Specialties (+2.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAUHY($26.4B) has a higher market cap than FONR($131M). SAUHY has higher P/E ratio than FONR: SAUHY (52.36) vs FONR (11.06). SAUHY YTD gains are higher at: 7.978 vs. FONR (-17.107). SAUHY has higher annual earnings (EBITDA): 678M vs. FONR (29.4M). SAUHY has higher revenues than FONR: SAUHY (2.32B) vs FONR (102M).
FONRSAUHYFONR / SAUHY
Capitalization131M26.4B0%
EBITDA29.4M678M4%
Gain YTD-17.1077.978-214%
P/E Ratio11.0652.3621%
Revenue102M2.32B4%
Total Cash53.3MN/A-
Total Debt35.8MN/A-
FUNDAMENTALS RATINGS
FONR vs SAUHY: Fundamental Ratings
FONR
SAUHY
OUTLOOK RATING
1..100
429
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
8379
PRICE GROWTH RATING
1..100
8249
P/E GROWTH RATING
1..100
3696
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAUHY's Valuation (19) in the null industry is somewhat better than the same rating for FONR (62) in the Medical Specialties industry. This means that SAUHY’s stock grew somewhat faster than FONR’s over the last 12 months.

SAUHY's Profit vs Risk Rating (65) in the null industry is somewhat better than the same rating for FONR (100) in the Medical Specialties industry. This means that SAUHY’s stock grew somewhat faster than FONR’s over the last 12 months.

SAUHY's SMR Rating (79) in the null industry is in the same range as FONR (83) in the Medical Specialties industry. This means that SAUHY’s stock grew similarly to FONR’s over the last 12 months.

SAUHY's Price Growth Rating (49) in the null industry is somewhat better than the same rating for FONR (82) in the Medical Specialties industry. This means that SAUHY’s stock grew somewhat faster than FONR’s over the last 12 months.

FONR's P/E Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for SAUHY (96) in the null industry. This means that FONR’s stock grew somewhat faster than SAUHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FONRSAUHY
RSI
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
62%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAUHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGDIX15.12N/A
N/A
TCW Relative Value Large Cap I
SEPIX12.12N/A
N/A
Saratoga Energy & Basic Materials I
REEAX13.89N/A
N/A
RBC Emerging Markets Equity A
MKILX20.02N/A
N/A
BlackRock International K
PAXGX16.46N/A
N/A
Impax Global Opportunities Investor

FONR and

Correlation & Price change

A.I.dvisor tells us that FONR and AZTA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FONR and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FONR
1D Price
Change %
FONR100%
+1.95%
AZTA - FONR
32%
Poorly correlated
+9.70%
OCX - FONR
30%
Poorly correlated
+0.35%
AVHHL - FONR
30%
Poorly correlated
N/A
KIDS - FONR
27%
Poorly correlated
+4.06%
SAUHY - FONR
25%
Poorly correlated
+7.60%
More

SAUHY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAUHY has been loosely correlated with SONVY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SAUHY jumps, then SONVY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAUHY
1D Price
Change %
SAUHY100%
+7.60%
SONVY - SAUHY
49%
Loosely correlated
-0.73%
ALGN - SAUHY
49%
Loosely correlated
+5.06%
SAUHF - SAUHY
47%
Loosely correlated
+6.34%
SMMNY - SAUHY
44%
Loosely correlated
-0.80%
CZMWY - SAUHY
38%
Loosely correlated
+2.44%
More